Hitoshi Ishii
Overview
Explore the profile of Hitoshi Ishii including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
742
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hayashino Y, Tsuboi S, Yamamoto Y, Ishii H
Diabetes Ther
. 2024 Nov;
15(12):2537-2555.
PMID: 39485624
Introduction: This survey assessed the perspectives of physicians, people with diabetes (PWD), and caregivers in Japan regarding initiation barriers and treatment burden associated with insulin therapy, and expectations for new...
2.
Ishii H, Kamiya H, Takahashi Y, Morimoto Y, Yabe D
Diabetes Ther
. 2024 Sep;
15(11):2381-2400.
PMID: 39347902
Introduction: Previous studies have shown that iGlarLixi, a fixed-ratio combination of insulin glargine 100 U/ml and lixisenatide, provides effective glycemic control in people with type 2 diabetes (T2D). The SIMPLIFY...
3.
Hayashino Y, Okamura S, Kurita N, Tsujii S, Ishii H
Acta Diabetol
. 2024 Aug;
62(3):375-383.
PMID: 39207491
Aims: This study aimed to identify the longitudinal associations between protein intake, and composite renal outcomes in people with type 2 diabetes. Methods: To examine the association between baseline total,...
4.
Ishii H, Maeda Y, Sato M, Cai Z, Imori M
Diabetes Ther
. 2024 May;
15(7):1577-1595.
PMID: 38760595
Introduction: People with diabetes require insulin to regulate blood glucose (BG); rapid-acting insulin analogs (RAIA) represent one approach for BG management. New fast-acting RAIA administered at the start of a...
5.
Hayashino Y, Goto M, Yamamoto T, Tsujii S, Ishii H
Diabetol Int
. 2024 Jan;
15(1):117-122.
PMID: 38264232
Introduction: The purpose of this study was to develop the Japanese version of the Problem Areas in Diabetes (PAID) scale, a measure of emotional adjustment to diabetes that has been...
6.
Ishii H, Oura T, Takeuchi M
Diabetes Ther
. 2023 Oct;
14(12):2173-2183.
PMID: 37843771
Introduction: Treatment satisfaction in diabetes management is vital to achieving long-term clinical outcomes. This analysis evaluated treatment satisfaction among patients with type 2 diabetes (T2D) after 52 weeks of treatment...
7.
Ishii H, Kamei N, Shimono D, Niiya T, Tosaki T, Kitazawa T, et al.
Diabetes Ther
. 2023 Jul;
14(10):1639-1658.
PMID: 37468684
Introduction: Preference for quality of life is important in deciding the treatment strategy for patients with type 2 diabetes mellitus. This study aimed to assess the effect of omarigliptin on...
8.
Okamura S, Niihata K, Nishiwaki H, Tsujii S, Ishii H, Hayashino Y, et al.
J Nephrol
. 2023 Jun;
36(9):2657-2660.
PMID: 37382876
No abstract available.
9.
Hayashino Y, Okamura S, Tsujii S, Ishii H
Can J Diabetes
. 2023 May;
47(6):519-524.
PMID: 37164214
Objectives: Our aim in this study was to investigate the prospective association between diabetes distress assessed with Problem Areas in Diabetes (PAID) survey scores at baseline and the subsequent risk...
10.
Mohri T, Okamoto S, Nishioka Y, Myojin T, Kubo S, Higashino T, et al.
Int J Environ Res Public Health
. 2023 Apr;
20(7).
PMID: 37047916
Patient data from the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) are used to assess the effect of biguanide administration on rates of lactic...